https://norgine.com/ 2024-11-27T12:22:24+00:00 1.00 https://norgine.com/other-norgine-websites/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/contact-us/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/raise-a-whistleblowing-concern/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/report-adverse-event/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/about-us/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/our-story/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/locations/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/our-management-structure/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/partnering/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/our-integrated-european-model/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/partnering-events/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/partnering-opportunities/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/terms-conditions-of-purchase/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/terms-and-conditions-of-sale/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/invoicing-guidelines/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/supplier-code-of-conduct/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/responsibility/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/compliance/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/work-patient-organisations/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/transparency-public-declarations/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/provision-of-unlicensed-medicines/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/products/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/clinical-trial-disclosure/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/careers/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/our-people/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/opportunities/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/media/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/terms-of-use/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/privacy-policy/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/cookie-policy/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/legal-entities/ 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/-aCV3vV4t6w 2024-11-27T12:22:24+00:00 0.80 https://norgine.com/whistleblowing-online-form-de/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/whistleblowing-online-form/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/whistleblowing-online-form-es/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/whistleblowing-online-form-fr/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/whistleblowing-online-form-it/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/whistleblowing-online-form-nl/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/whistleblowing-online-form-pt/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/-aCV3vV4t6w?feature=oembed 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/loVdVmUtHRc?feature=oembed 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NBV-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:25:33+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NBV-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services_nl.pdf 2023-10-10T16:25:32+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NHBV-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:29:37+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NHBV-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services_nl.pdf 2023-10-10T16:29:36+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NNV-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:46:50+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/Conditions-Generales-de-Norgine-NV-pour-lAchat-de-Biens-et-de-Services.pdf 2023-10-12T12:32:51+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NNV-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services_nl.pdf 2023-10-10T16:46:49+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NGmbH-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:50:55+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NGmbH-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services_de.pdf 2023-10-10T16:50:54+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NLTD-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:54:18+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NPL-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:55:26+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/Conditions-Generales-de-Norgine-SAS-pour-lAchat-de-Biens-et-de-Services.pdf 2023-10-12T12:33:31+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NSAS-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:57:38+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/Conditions-Generales-de-Norgine-Pharma-pour-lAchat-de-Biens-et-de-Service.pdf 2023-10-12T12:34:26+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/NPharma-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:59:12+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/SPAG-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T17:02:46+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/SPAG-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services_de.pdf 2023-10-10T17:02:45+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/Conditions-Generales-de-SPAG-pour-lAchat-de-Biens-et-de-Services.pdf 2023-10-12T12:30:34+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/Azanta-AS-Terms-and-conditions-for-the-Purchase-of-Goods-and-Services.pdf 2023-10-10T16:10:41+00:00 0.64 https://norgine.com/wp-content/uploads/2023/10/Azanta-Danmark-AS-Terms-and-conditions-for-the-Purchase-of-Goods-and-Servi.pdf 2023-10-10T16:10:42+00:00 0.64 https://norgine.com/wp-content/uploads/2024/08/Terms-and-conditions-for-the-supply-of-goods-Final-Version-June-24.pdf 2024-08-15T11:57:16+00:00 0.64 https://norgine.com/wp-content/uploads/2024/11/NGMBH-Terms-and-Conditions-for-Sale-November-2024-EN.pdf 2024-11-12T13:20:02+00:00 0.64 https://norgine.com/wp-content/uploads/2024/11/NGMBH-Terms-and-Conditions-for-Sale-November-2024-DE.pdf 2024-11-12T13:19:48+00:00 0.64 https://norgine.com/wp-content/uploads/2024/08/Dutch-Richtlijnen-voor-het-indienen-van-facturen.pdf 2024-08-23T10:52:41+00:00 0.64 https://norgine.com/wp-content/uploads/2024/08/German-Richtlinien-fur-die-Einreichung-von-Rechnungen.pdf 2024-08-23T10:52:47+00:00 0.64 https://norgine.com/wp-content/uploads/2024/08/English-Norgine-Global-Invoicing-Guidelines.pdf 2024-08-23T10:52:44+00:00 0.64 https://norgine.com/wp-content/uploads/2024/08/French-Soumission-des-factures-fournisseurs.pdf 2024-08-23T10:52:45+00:00 0.64 https://norgine.com/wp-content/uploads/2024/08/Spanish-Directrices-para-la-presentacion-de-facturas.pdf 2024-08-23T10:52:48+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-NL.pdf 2024-10-02T15:07:58+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-DE.pdf 2024-10-02T15:07:29+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-FR.pdf 2024-10-02T15:07:38+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-ENG.pdf 2024-10-02T15:07:32+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-ES.pdf 2024-10-02T15:07:19+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-IT.pdf 2024-10-02T15:07:51+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/Norgine-Supplier-Code-of-Conduct-PT.pdf 2024-10-02T15:07:24+00:00 0.64 https://norgine.com/compliance/compliance-overview-de/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/compliance/compliance-overview/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/compliance/compliance-overview-es/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/compliance/compliance-overview-fr/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/compliance/compliance-overview-it/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/compliance/compliance-overview-nl/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/compliance/compliance-overview-pt/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/wp-content/uploads/2020/03/POrg-Methodology-Notes-2020.pdf 2020-03-27T16:16:59+00:00 0.64 https://norgine.com/wp-content/uploads/2024/03/2024-POrgDisclosure-2023Data-Final-25Mar24.pdf 2024-03-26T15:02:28+00:00 0.64 https://norgine.com/wp-content/uploads/2023/03/2023-POrgDisclosure-2022Data-Final-Version-21Mar23.pdf 2023-03-23T13:01:10+00:00 0.64 https://norgine.com/wp-content/uploads/2022/03/2022-POrgDisclosure-2021Data-Final-Updated-25-Mar-2022.pdf 2022-03-28T08:01:55+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Norgine-Pharma-GmbH-Offenlegung-2024-fur-2023.pdf 2024-06-25T12:21:27+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Austria-2022.pdf 2023-06-12T15:18:14+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Austria-2021.pdf 2022-06-14T12:31:56+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/TP-1219_Methodology-Notes-Austria_2023.pdf 2024-06-17T10:30:40+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/TP-1219_Methodology-Notes-Austria_2022.pdf 2023-06-12T15:18:13+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/TP-1219_Methodology-Notes-Austria_2021.pdf 2022-06-14T12:31:50+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Transparency-Nordics-Denmark-2023-corrected1.pdf 2024-06-17T10:36:09+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Nordics-Denmark-13Jun2022.pdf 2023-06-15T13:46:04+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Nordics-Denmark-2021.pdf 2022-06-14T13:32:17+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/DA_Methodology-Notes-Norgine-Nordics-2024.pdf 2024-06-17T10:36:08+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/DA_Methodology-Notes-Norgine-Nordics-2023-1.pdf 2023-06-15T13:47:16+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/DA_Methodology-Notes-Norgine-Nordics-2022.pdf 2022-06-14T13:33:28+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Transparency-UKIE-Ireland-2023.pdf 2024-06-17T10:39:59+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-UKIE-Ireland-2022.pdf 2023-06-12T15:43:20+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Ireland-2022.xls.pdf 2022-06-15T11:59:42+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Norgine_Methodology_Ireland_2024.pdf 2024-06-17T10:39:58+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Norgine_Methodology_Ireland_2023.pdf 2023-06-12T15:43:21+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Norgine_Methodology_Ireland_2022.pdf 2022-06-15T12:01:16+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Nordics-Finland-2022.xls.pdf 2023-06-13T14:40:34+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Nordics-Finland-2021.pdf 2022-06-15T11:47:27+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/FI_Methodology-Notes-Norgine-Nordics-2024.pdf 2024-06-17T10:54:51+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/FI_Methodology-Notes-Norgine-Nordics-2023.pdf 2023-06-12T16:09:15+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/FI_Methodology-Notes-Norgine-Nordics-2022.pdf 2022-06-15T11:47:08+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Transparency-Germany-2023.pdf 2024-06-17T13:19:27+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Germany-2022.pdf 2023-06-12T16:02:06+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Germany-2021_final.pdf 2022-06-15T11:55:01+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Methodology-Note-2023-Germany.pdf 2024-06-17T13:19:29+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Methodology-Note-2022.pdf 2023-06-12T16:02:09+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Methodology-Note-2021-Germany.pdf 2022-06-15T11:55:14+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/2024-Italy-ToV-Declaration-for-2023-data.ita_.pdf 2024-06-17T10:50:09+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Norgine-Italy_Transparency-Disclosure-2022.pdf 2023-06-13T10:12:06+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Italy-2022-2021-Disclosure.pdf 2022-06-15T12:03:31+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/2024-Italy-Methodology-Notes-for-2023-data.ita_.pdf 2024-06-17T10:50:08+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Norgine-Italy_Methodology-Notes-2023.pdf 2023-06-13T10:12:08+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Methodology-Note-2022_Italy.pdf 2022-06-15T12:03:42+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Norgine-2023-Methodology-Notes-Netherlands.pdf 2023-06-13T10:15:53+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Norgine-2022-Methodology-Notes-Netherlands.pdf 2022-06-15T12:07:43+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Transparency-Nordics-Norway-2023.pdf 2024-06-17T12:49:18+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Nordics-Norway-2022.xls.pdf 2023-06-13T14:39:45+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Nordics-Norway-2021.pdf 2022-06-15T12:11:50+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/NO_Methodology-Notes-Norgine-Nordics-2024.pdf 2024-06-17T12:49:18+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/NO_Methodology-Notes-Norgine-Nordics-2023.pdf 2023-06-13T10:20:20+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/NO_Methodology-Notes-Norgine-Nordics-2022.pdf 2022-06-15T12:11:37+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/2022Data-Disclosure_Poland-9Jun23.pdf 2023-06-13T11:49:09+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/MethNotesPoland2022-Final_TP-1219.pdf 2023-06-13T11:49:04+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Final_Export_Spain_ToV_2023.pdf 2024-06-17T13:03:34+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Final_Export_Spain_ToV_2022.pdf 2023-06-15T12:14:01+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Final_Export_Spain_ToV_2021.pdf 2022-06-22T12:34:28+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Spain-Methodology-Note-2024-2023-data_HCP_HCO_POrg.pdf 2024-06-17T13:03:35+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Spain-Methodology-Note-2023-2022-data_HCP_HCO_POrg.pdf 2023-06-15T12:14:47+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Spain-Methodology-Note-2022-2021-data_HCP_HCO_POrg.pdf 2022-06-15T12:19:24+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Transparency-Nordics-Sweden-2023.Updated-to-one-side.pdf 2024-06-17T13:11:30+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Nordics-Sweden-2Jun.pdf 2023-06-15T13:47:53+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Nordics-Sweden-2021.pdf 2022-06-15T12:27:23+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/SE_Methodology-Notes-Norgine-Nordics-2024.pdf 2024-06-17T13:11:30+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/SE_Methodology-Notes-Norgine-Nordics-2023.pdf 2023-06-15T13:48:42+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/SE_Methodology-Notes-Norgine-Nordics-2022.pdf 2022-06-15T12:26:52+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/Transparency-Liechtenstein-Switzerland-2023.pdf 2024-06-25T12:21:17+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/Transparency-Switzerland-2022.pdf 2023-06-15T12:16:28+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/Transparency-Switzerland-2021.pdf 2022-06-15T12:30:10+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/TP-1219_Methodology-Notes-Switzerland_2023.pdf 2024-06-17T13:14:20+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/TP-1219_Methodology-Notes-Switzerland_2022.pdf 2023-06-15T12:20:29+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/TP-1219_Methodology-Notes-Switzerland_2021_final.pdf 2022-06-15T12:30:36+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/2023-Medical-Device-Disclosure-2022-Data-Final-Version-Approved.pdf 2023-06-13T10:43:03+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/2022-Medical-Device-Disclosure-2021-Data.pdf 2022-06-17T09:45:52+00:00 0.64 https://norgine.com/wp-content/uploads/2024/06/annual-disclosure-template-for-MOP-and-the-patient-2023-.pdf 2024-06-17T13:27:20+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/annual-disclosure-template-for-MOP-and-the-patient-2022-1.pdf 2023-06-16T13:18:43+00:00 0.64 https://norgine.com/wp-content/uploads/2022/06/2021-annual-disclosure-for-MOP-and-patients.pdf 2022-06-23T10:41:57+00:00 0.64 https://norgine.com/wp-content/uploads/2023/06/annual-disclosure-template-for-MOP-and-the-patient-2022.pdf 2023-06-13T10:48:49+00:00 0.64 https://norgine.com/wp-content/uploads/2020/12/Cover-Page-1.pdf 2020-12-02T15:59:12+00:00 0.64 https://norgine.com/wp-content/uploads/2020/12/NER1006-03-2014-DAYB-Lay-Summary.pdf 2020-12-01T16:02:15+00:00 0.64 https://norgine.com/wp-content/uploads/2020/12/NER1006-02-2014-MORA-Lay-Summary.pdf 2020-12-01T16:02:14+00:00 0.64 https://norgine.com/wp-content/uploads/2020/12/NER1006-01-2014-NOCT-Lay-Summary.pdf 2020-12-01T16:02:13+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/CFLD-NRL972-Summary-Certified-Final-Oct14.pdf 2017-03-05T12:19:42+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL-972-IVCO-Study-Summary-Final-.pdf 2017-03-05T12:18:52+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL-972-PAIR-Study-FINAL-approved-Dec2014.pdf 2017-03-05T12:18:02+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/IN-X-Final.pdf 2017-03-05T12:17:12+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL-972-CIR-Study-Report-FINAL-Mar2015.pdf 2017-03-05T12:16:24+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL972_ETOH.pdf 2017-03-05T12:15:22+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL972_IV.pdf 2017-03-05T12:14:26+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL972_VOLT.pdf 2017-03-05T12:13:36+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL972_QTC.pdf 2017-03-05T12:12:42+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL972_KENDLE.pdf 2017-03-05T12:11:40+00:00 0.64 https://norgine.com/wp-content/uploads/2017/03/NRL994-01-2007-GLO-Final-04Aug14.pdf 2017-03-05T12:10:32+00:00 0.64 https://norgine.com/press_release/norgine-announces-appointment-of-new-ceo-janneke-van-der-kamp/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/press_release/norgine-b-v-submits-marketing-authorisation-application-via-project-orbis-for-eflornithine-difluoromethylornithine-dfmo-in-high-risk-neuroblastoma/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/press_release/fennec-pharmaceuticals-and-norgine-enter-into-exclusive-licensing-agreement-to-commercialize-pedmarqsi-in-europe-australia-and-new-zealand/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/media-releases-archive/ 2024-11-27T12:22:24+00:00 0.64 https://norgine.com/wp-content/uploads/2024/10/DE-Norgine-Business-Code-2024.pdf 2024-10-02T14:40:23+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-German-2024.pdf 2024-08-12T11:00:59+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-AML-Policy.pdf 2023-11-01T11:14:12+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-AFTE-Policy.pdf 2023-11-01T11:14:47+00:00 0.51 https://norgine.com/wp-content/uploads/2023/12/Fraud-Policy-2023-Dec-1.pdf 2023-12-19T17:34:56+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Trade-Controls-Policy.pdf 2023-11-01T11:15:20+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-de.pdf 2023-10-18T17:00:01+00:00 0.51 https://norgine.com/wp-content/uploads/2023/12/Donations-and-Grants-Policy.pdf 2023-12-19T17:34:46+00:00 0.51 https://norgine.com/wp-content/uploads/2024/10/ENG-Norgine-Business-Code.pdf 2024-10-02T14:50:21+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-English-2024.pdf 2024-08-12T11:09:03+00:00 0.51 https://norgine.com/wp-content/uploads/2024/04/AFTE-Policy-.pdf 2024-04-15T12:01:27+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-eng.pdf 2023-10-18T17:00:02+00:00 0.51 https://norgine.com/wp-content/uploads/2024/10/ES-Norgine-Business-Code-2024.pdf 2024-10-02T14:42:00+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-Spanish-2024.pdf 2024-08-12T11:06:23+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-es.pdf 2023-10-18T17:00:03+00:00 0.51 https://norgine.com/wp-content/uploads/2024/10/FR-Norgine-Business-Code-2024.pdf 2024-10-02T14:43:29+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-French-2024.pdf 2024-08-12T11:07:29+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-fr.pdf 2023-10-18T17:00:04+00:00 0.51 https://norgine.com/wp-content/uploads/2024/10/IT-Norgine-Business-Code-2024.pdf 2024-10-02T14:33:05+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-Italian-2024.pdf 2024-08-12T11:08:06+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-it.pdf 2023-10-18T17:00:04+00:00 0.51 https://norgine.com/wp-content/uploads/2024/10/NL-Norgine-Business-Code-2024.pdf 2024-10-02T14:36:00+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-Dutch-2024.pdf 2024-08-12T11:07:00+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-nl.pdf 2023-10-18T17:00:05+00:00 0.51 https://norgine.com/wp-content/uploads/2024/10/PT-Norgine-Business-Code-2024.pdf 2024-10-02T14:37:11+00:00 0.51 https://norgine.com/wp-content/uploads/2024/08/ABC-Portuguese-2024.pdf 2024-08-12T11:08:38+00:00 0.51 https://norgine.com/wp-content/uploads/2023/10/Norgine-Whistleblowing-Policy-pt.pdf 2023-10-18T17:00:05+00:00 0.51 https://norgine.com/press_release/norgine-strengthens-senior-leadership-with-the-appointment-of-saulo-martiniano-as-chief-operating-officer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/european-study/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-announces-closing-of-investment-from-goldman-sachs-asset-management/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-announces-investment-from-goldman-sachs-asset-management/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-announces-appointment-of-alan-butcher-as-chief-corporate-development-officer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-announces-senior-management-changes-christopher-bath-appointed-chief-executive-officer-peter-stein-to-assume-role-of-executive-chairman/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-celebrates-30-years-of-the-bowel-preparations-used-in-colonoscopy-to-help-prevent-and-diagnose-gastrointestinal-diseases-including-colorectal-cancer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/new-data-in-the-european-heart-journal-show-ciraparantag-reverses-the-anticoagulant-activity-of-apixaban-and-rivaroxaban-in-elderly-patients/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-and-us-worldmeds-enter-into-exclusive-licensing-agreement-to-commercialise-dfmo-eflornithine-in-europe-commonwealth-of-independent-states-australia-and-new-zealand/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-enters-into-exclusive-distribution-agreement-for-the-commercialisation-of-plenvu-in-china-with-beijing-podconley-pharmaceutical-technology-development-co-ltd/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/5360/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-acquires-setofilm-ondansetron-oral-dispersible-film-in-europe-australia-and-new-zealand-from-apr-applied-pharma-research-s-a/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-enters-into-an-agreement-to-dispose-of-its-rights-to-emselex-darifenacin-in-europe-to-pharma/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-completes-important-regulatory-milestone-for-angusta-misoprostol-in-europe-for-oral-induction-of-labour/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/olympus-acquires-arc-medical-design-limited-from-norgine-b-v/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-enters-into-exclusive-distribution-agreement-for-the-commercialisation-of-glyceryl-trinitrate-transdermal-patch-with-medfatop-ltd-in-vietnam/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-receives-rospa-gold-medal-for-health-and-safety-sixth-year-in-a-row/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/amag-pharmaceuticals-and-norgine-b-v-enter-into-exclusive-licensing-agreement-to-commercialize-ciraparantag-in-europe-australia-and-new-zealand/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-senior-management-changes-christopher-bath-appointed-chief-operating-officer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-are-here-to-support-you-wherever-we-are-coronavirus-covid19/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/from-all-of-us-at-norgine-we-would-like-to-say-thank-you-coronavirus-covid19/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-acquires-azanta-a-s-strengthening-its-position-as-a-leading-european-specialist-pharmaceutical-company/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-enters-into-exclusive-licence-and-distribution-agreements-for-the-commercialisation-of-plenvu-in-a-number-of-countries-in-latin-america-southern-africa-central-and-eastern-europe/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/ueg-week-exhibition-celebrates-50-years-of-colonoscopy-in-preventing-and-diagnosing-gastrointestinal-diseases-including-colorectal-cancer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/spepharm-ag-wins-case-against-eisai-inc-in-united-states-district-court-for-district-of-delaware/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-recognised-for-excellence-in-health-and-safety-with-rospa-gold-medal-award-fifth-year-in-a-row/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/new-study-shows-rifaximin-significantly-reduced-the-number-and-length-of-hospitalisations-in-patients-with-overt-hepatic-encephalopathy-he-awaiting-liver-transplatation/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-marks-50th-anniversary-of-pharmaceutical-manufacturing-site-in-wales/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/new-real-world-study-shows-rifaximin-%ef%81%a1-significantly-reduced-hospitalisation-in-patients-with-overt-hepatic-encephalopathy-he-when-added-to-lactulose/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-new-study-highlights-need-to-increase-public-understanding-of-important-role-of-colonoscopy-in-preventing-and-diagnosing-gastrointestinal-diseases-including-colorectal-cancer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-enters-into-a-new-partnership-with-adacyte-therapeutics-to-commercialise-adacolumn-in-switzerland/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-expands-its-partnership-with-noventure-to-commercialise-gelsectan-in-france/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-and-korea-pharma-co-ltd-enter-into-exclusive-licence-agreement-for-the-commercialisation-of-plenvu-in-the-republic-of-korea/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/plenvu-ner1006-the-first-1-litre-bowel-preparation-to-show-superior-high-quality-segmental-cleansing-of-the-colon-compared-to-standard-of-care/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/new-norgine-data-reveal-gap-between-patient-expectations-and-clinical-reality-in-bowel-preparation-for-colonoscopy1/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-to-present-data-for-plenvu-and-xifaxan-at-the-united-european-gastroenterology-week-ueg/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-b-v-to-divest-its-canadian-assets-acquired-through-merus-labs-international-inc-to-searchlight-pharma/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/4139/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-releases-h1-2018-results/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-and-its-partner-salix-announce-the-us-launch-of-plenvu/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-de-espana-lanza-lymphoseek/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-lancerer-plenvu-i-danmark/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/neue-prazision-in-der-wachterlymphknoten-detektion-lymphoseek-jetzt-auch-in-deutschland-auf-dem-markt/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/endoscopy-publishes-the-dayb-phase-iii-trial-for-plenvu-ner1006-the-first-one-litre-peg-bowel-preparation/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/endoscopy-publishes-the-mora-phase-iii-trial-for-plenvu-ner1006-the-only-1-litre-peg-based-bowel-preparationi/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-opens-its-new-german-offices-in-wettenberg/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/termination-of-license-and-development-agreement-for-oblean-tablets-120mg-for-treatment-of-obesity/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-welcomes-the-new-world-health-organisation-who-icd-11-coding-for-hepatic-encephalopathy/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-france-with-100-years-of-expertise-celebrates-new-manufacturing-investment/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-and-its-partner-salix-present-new-data-from-plenvu-ner1006-phase-3-studies-at-digestive-disease-week-ddw-2018/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-announces-us-fda-approval-for-plenvu-ner1006-1-litre-peg-based-bowel-cleansing-preparation-for-colonoscopy/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/new-data-show-that-high-quality-cleansing-improves-lesion-detection-during-colonoscopy-compared-to-adequate-cleansing/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/new-data-show-that-rifaximin-%ef%81%a1-reduces-systemic-inflammation-in-patients-with-cirrhosis-and-chronic-hepatic-encephalopathy/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/rifaximin-%ef%81%a1-reduces-the-incidence-of-sepsis-and-all-cause-admissions-whilst-on-the-liver-transplant-waiting-list-and-hospital-admissions/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/nhs-england-to-fund-endocuff-vision-for-bowel-cancer-screening-colonoscopies/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-is-calling-the-nhs-to-remove-constipation-from-the-list-of-restricted-conditions-in-proposed-ccgs-guidance-constipation-is-a-very-serious-condition/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-committed-prevention-colorectal-cancer/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgines-performance-2017-priorities-2018/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/uk-high-court-justice-rules-endocuff-endocuff-vision-patents-design-rights-valid-infringed/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/positive-new-data-show-superiority-plenvu-1-litre-peg-preparation-compared-moviprep-2-litre-peg-ascorbate/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgines-plenvu-ner1006-receives-approval-germany-bowel-cleansing-adults-prior-procedure-requiring-clean-bowel/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/endocuff-vision-significantly-improves-adenoma-detection-rate-colorectal-cancer-detection-colonoscopy-bowel-cancer-screening-patients/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-announces-publication-prosper-study-design-hepatology-medicine-policy-journal/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-opens-new-corporate-headquarters-amsterdam/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgines-plenvu-ner1006-receives-austrian-australian-french-irish-italian-portuguese-approvals-bowel-cleansing-adults-prior-procedure-requiring-clean-bowel/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/press_release/norgine-launches-lymphoseek%e2%96%bc-finland-sweden/ 2024-11-27T12:22:24+00:00 0.51 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/GJqZqAtW0Rg?feature=oembed 2024-11-27T12:22:24+00:00 0.41 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/AUwtXLU82Bw?feature=oembed 2024-11-27T12:22:24+00:00 0.41 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/TJAt43oxsE8?feature=oembed 2024-11-27T12:22:24+00:00 0.41 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/7FePEHuvK1o?feature=oembed 2024-11-27T12:22:24+00:00 0.41 https://norgine.com/wp-admin/admin-ajax.php?action=gdpr_iframe_blocker&src=https://www.youtube.com/embed/gPVKLGApOIY?feature=oembed 2024-11-27T12:22:24+00:00 0.41 https://norgine.com/key_feature/scope-change-next-european-colonoscopy-services/ 2024-11-27T12:22:24+00:00 0.41 https://norgine.com/wp-content/uploads/2017/09/Scope-for-change-what-next-for-European-colonoscopy-services.pdf 2017-09-20T09:37:30+00:00 0.33